glp 1/gip receptor agonist Science Behind 1 GIP and Glucagon Agonists for Obesity Research | News & Announcements Major physiological roles of GLP-1
Description
In late April 2025, the FDA issued a key update regarding the use of compounded GLP-1 receptor agonists like semaglutide and tirzepatide
Learn about the benefits and practical steps for transitioning patients from GLP-1 RAs to dual GLP-1/GIP receptor agonists, such as tirzepatide, to improve glycemic control in adults with type 2 diabetes.
Ozempic was created thanks to research on Gila monsters, the only venomous lizard in the US
Commitment to Privacy
Supports healthy blood sugar metabolism*
